Amphastar Pharmaceuticals, Inc. Reports Financial Results For The Three Months Ended September 30, 2016

Reports Net Revenues of $64.2 Million for the Three Months Ended September 30, 2016

RANCHO CUCAMONGA, Calif., Nov. 08, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) (“Amphastar” or the “Company”) today reported results for the three months ended September 30, 2016.

Third Quarter Highlights

• Net revenues of $64.2 million for the third quarter
• GAAP net income of $3.9 million, or $0.08 per diluted share for the third quarter
• Adjusted non-GAAP net income of $6.6 million, or $0.14 per diluted share for the third quarter

Dr. Jack Zhang, Amphastar’s CEO, commented:  “We are pleased with the Company’s profitability for the quarter and look forward to potential product approvals in the coming months.”